Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation

• DOI: 10.3389/fphar.2024.1399625
• Publication Date: 2024-04-24T04:39:16Z
• Authors: Hongyuan Jiang; Xuliang Zhao; Jinhui Zang; Ruijiao Wang; Jiake Gao; Jinli Chen; Tengbo Yu
• Keywords: immunology; Pharmacology; prognosis diagnosis model; 0303 health sciences; 03 medical and health sciences; osteosarcoma; GSK3β/βcatenin signaling pathway; CHMP4C; Therapeutics. Pharmacology; RM1-950

To investigate the immune mechanism of osteosarcoma (OS)-specific markers to mitigate bone destruction in aggressive OS, prone recurrence and metastasis.